We’re excited to announce that Akebia Therapeutics and Keryx Biopharmaceuticals have merged, creating a fully integrated company focused on the development and commercialization of therapeutics for patients with kidney disease. The combined company is called Akebia. To learn about the merger, please read our press release. Read about the merger here »

The 2016 Albert Lasker Basic Medical Research Award honors three physician-scientists for their discovery of the pathway by which cells from human and most animals sense and adapt to changes in oxygen availability, a process that is essential for survival. Scientists had long appreciated that the success of today's dominant life forms hinges on oxygen, yet little was known about their responses to it. Read more »